Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Prescription profile and safety of oral capecitabine in metastatic colorectal cancer patients

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: FERNáNDEZ BARRANTES, Cristina (Caja Costarricense de Seguro Social/ Hospital San Juan de Dios, Drug Information Center, San José, Costa Rica)
  • Co-author(s): Angelina Zumbado Arroyo:Pharmacy Service,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica|Cristina Fernández Barrantes:Drug Information Center,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica
  • Abstract:

    Capecitabine is an oral fluoropyrimidine effective in the treatment of metastatic colorectal cancer, has a toxicity profile well established. The most common adverse reactions reported are hand-foot syndrome, diarrhea, stomatitis, nausea and vomiting. Capecitabine is generally considered well tolerated.

    Observacional retrospective study, based on a

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses